Coding and Coverage

Vascular

Abbott annually updates coding and reimbursement information for hospital inpatient, hospital outpatient, and ASC settings, as well as physician rates.  Click on our guides to easily look up CPT codes, ICD-10 codes, physician RVUs, and Medicare national average reimbursement rates for vascular products.

Coding Guides and Resources for Vascular Therapies

Coronary

Coronary Microvascular Dysfunction

ICD-10 Diagnosis Codes Effective October 1, 2023

Coronary microvascular dysfunction is now formally recognized as a diagnosis through the creation of four ICD-10-CM codes effective October 1, 2023. The new codes can be found on the CDC’s website. The new codes describe the various forms of coronary microvascular dysfunction that will help clinicians identify and accurately diagnose patients with CMD. For more information on CMD, please go to Coronary Microvascular Dysfunction Overview on Abbott's website.

The four ICD-10 diagnosis codes describing Coronary Microvascular Dysfunction are:

I20.81 – Angina pectoris with coronary microvascular dysfunction
I21.B – Myocardial infarction with coronary microvascular dysfunction
I24.81 – Acute coronary microvascular dysfunction
I25.85 – Chronic coronary microvascular dysfunction

Peripheral

Vessel Closure Details

The following code has been assigned to occlusive devices by CMS: G0269

G0269 is defined as: placement of an occlusive device in either a venous or arterial access site, post-surgical or interventional procedure. Code G0269 should be used on Medicare claims to record the placement of the vasoseal and for other payers as directed.

Everolimus Eluting Resorbable Scaffold 

ICD-10 Procedure Codes Effective October 1, 2024

Centers for Medicare and Medicaid Services (CMS) has issued the following New Technology ICD-10 PCS codes for the implantation of everolimus-eluting resorbable scaffold in below-the-knee arteries (e.g., Esprit™ BTK Everolimus Eluting Resorbable Scaffold System).

The new ICD-10 PCS codes are for use in the hospital inpatient setting, effective October 1, 2024.

The ICD-10 PCS codes describing everolimus-eluting resorbable scaffold implantation are:

X27P3TA - Dilation of Right Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

X27Q3TA - Dilation of Left Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

X27R3TA - Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

X27S3TA - Dilation of Left Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

X27T3TA - Dilation of Right Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

X27U3TA -Dilation of Left Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10

Return to Reimbursement Home

Contact us

If you require additional assistance, we are happy to help.
 

Reimbursement Hotline

General coding advice
8 a.m. – 5 p.m. CT
Monday–Friday

phone graphic

Field Reimbursement Team

To contact a reimbursement specialist for coverage, coding or payment questions:

email graphic
Health Economics & Reimbursement Disclaimer

This material and the information contained herein is for general information purposes only and is not intended, and does not constitute, legal, reimbursement, business, clinical, or other advice. Furthermore, it is not intended to and does not constitute a representation or guarantee of reimbursement, payment, or charge, or that reimbursement or other payment will be received. It is not intended to increase or maximize payment by any payer. Abbott makes no express or implied warranty or guarantee that the list of codes and narratives in this document is complete or error-free. Similarly, nothing in this document should be viewed as instructions for selecting any particular code, and Abbott does not advocate or warrant the appropriateness of the use of any particular code. The ultimate responsibility for coding and obtaining payment/reimbursement remains with the customer. This includes the responsibility for accuracy and veracity of all coding and claims submitted to third-party payers. In addition, the customer should note that laws, regulations, and coverage policies are complex and are updated frequently, and, therefore, the customer should check with its local carriers or intermediaries often and should consult with legal counsel or a financial, coding, or reimbursement specialist for any questions related to coding, billing, reimbursement, or any related issues. This material reproduces information for reference purposes only. It is not provided or authorized for marketing use.

MAT-2205192 v3.0

MAT-2402008 v3.0